A dominant negative isoform of the long QT syndrome 1 gene product

被引:70
作者
Demolombe, S
Baró, I
Péréon, Y
Bliek, J
Mohammad-Panah, R
Pollard, H
Morid, S
Mannens, M
Wilde, A
Barhanin, J
Charpentier, F
Escande, D
机构
[1] Hop Hotel Dieu, INSERM CJF 96 01, Lab Physiopathol & Pharmacol Cellulaires & Mol, F-44093 Nantes, France
[2] UPR CNRS 411, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France
[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1074/jbc.273.12.6837
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the KvLQT1 gene are the cause of the long QT syndrome I, KvLQT1 gene product is associated with the regulator protein IsK to produce a component of the delayed rectifier K+ current in cardiac myocytes, We identified an N-terminal truncated isoform of the KvLQT1 gene product, referred to as isoform 2, In RNase protection assays, isoform 2 represented 28.1 +/- 0.6% of the total KvLQT1 expression in the human adult ventricle, COS-7 cells injected intranuclearly with KvLQT1 isoform 1 cDNA exhibited a fast-activating K+ current, whereas those injected with a KvLQT1 isoform 1 plus IsK cDNA showed a slow-activating K+ current, Cells injected with KvLQT1 isoform 2 plasmid showed no detectable K+ current, Those injected with a 1/1 isoform 2/isoform 1 ratio showed no detectable H+ current, Those injected with 1/5 and 2/5 ratios showed a K+ current with markedly reduced amplitude, Coexpression of the IsK regulator consistently reduced the dominant negative effects of isoform 2, Our results indicate that KvLQT1 isoform 2 exerts a pronounced negative dominance on isoform 1 channels and that the cardiac KvLQT1 K+ channel complex is composed of at least three different proteins as follows: isoform 1, isoform 2, and IsK.
引用
收藏
页码:6837 / 6843
页数:7
相关论文
共 23 条
  • [11] Pereon Y, 1997, PFLUG ARCH EUR J PHY, V433, P221
  • [12] Multiple mechanisms in the long-QT syndrome - Current knowledge, gaps, and future directions
    Roden, DM
    Lazzara, R
    Rosen, M
    Schwartz, PJ
    Towbin, J
    Vincent, GM
    [J]. CIRCULATION, 1996, 94 (08) : 1996 - 2012
  • [13] Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity
    Romey, G
    Attali, B
    Chouabe, C
    Abitbol, I
    Guillemare, E
    Barhanin, J
    Lazdunski, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) : 16713 - 16716
  • [14] Coassembly of K(v)LQT1 and minK (IsK) proteins to form cardiac I-Ks potassium channel
    Sanguinetti, MC
    Curran, ME
    Zou, A
    Shen, J
    Spector, PS
    Atkinson, DL
    Keating, MT
    [J]. NATURE, 1996, 384 (6604) : 80 - 83
  • [15] 2 COMPONENTS OF CARDIAC DELAYED RECTIFIER K+ CURRENT - DIFFERENTIAL SENSITIVITY TO BLOCK BY CLASS-III ANTIARRHYTHMIC AGENTS
    SANGUINETTI, MC
    JURKIEWICZ, NK
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 1990, 96 (01) : 195 - 215
  • [16] SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114
  • [17] Inner ear defects induced by null mutation of the isk gene
    Vetter, DE
    Mann, JR
    Wangemann, P
    Liu, JZ
    McLaughlin, KJ
    Lesage, F
    Marcus, DC
    Lazdunski, M
    Heinemann, SF
    Barhanin, J
    [J]. NEURON, 1996, 17 (06) : 1251 - 1264
  • [18] PROMOTER-SPECIFIC IMPRINTING OF THE HUMAN INSULIN-LIKE GROWTH FACTOR-II GENE
    VU, TH
    HOFFMAN, AR
    [J]. NATURE, 1994, 371 (6499) : 714 - 717
  • [19] SCN5A MUTATIONS ASSOCIATED WITH AN INHERITED CARDIAC-ARRHYTHMIA, LONG QT SYNDROME
    WANG, Q
    SHEN, JX
    SPLAWSKI, I
    ATKINSON, D
    LI, ZZ
    ROBINSON, JL
    MOSS, AJ
    TOWBIN, JA
    KEATING, MT
    [J]. CELL, 1995, 80 (05) : 805 - 811
  • [20] Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
    Wang, Q
    Curran, ME
    Splawski, I
    Burn, TC
    Millholland, JM
    VanRaay, TJ
    Shen, J
    Timothy, KW
    Vincent, GM
    deJager, T
    Schwartz, PJ
    Towbin, JA
    Moss, AJ
    Atkinson, DL
    Landes, GM
    Connors, TD
    Keating, MT
    [J]. NATURE GENETICS, 1996, 12 (01) : 17 - 23